BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 23821509)

  • 1. Neutrophilic reversible allograft dysfunction (NRAD) and restrictive allograft syndrome (RAS).
    Verleden SE; Vandermeulen E; Ruttens D; Vos R; Vaneylen A; Dupont LJ; Van Raemdonck DE; Vanaudenaerde BM; Verleden GM
    Semin Respir Crit Care Med; 2013 Jun; 34(3):352-60. PubMed ID: 23821509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction.
    Sato M; Waddell TK; Wagnetz U; Roberts HC; Hwang DM; Haroon A; Wagnetz D; Chaparro C; Singer LG; Hutcheon MA; Keshavjee S
    J Heart Lung Transplant; 2011 Jul; 30(7):735-42. PubMed ID: 21419659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current views on chronic rejection after lung transplantation.
    Verleden GM; Vos R; Vanaudenaerde B; Dupont L; Yserbyt J; Van Raemdonck D; Verleden S
    Transpl Int; 2015 Oct; 28(10):1131-9. PubMed ID: 25857869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new classification system for chronic lung allograft dysfunction.
    Verleden GM; Raghu G; Meyer KC; Glanville AR; Corris P
    J Heart Lung Transplant; 2014 Feb; 33(2):127-33. PubMed ID: 24374027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bronchiolitis obliterans syndrome and restrictive allograft syndrome: do risk factors differ?
    Verleden SE; Ruttens D; Vandermeulen E; Vaneylen A; Dupont LJ; Van Raemdonck DE; Verleden GM; Vanaudenaerde BM; Vos R
    Transplantation; 2013 May; 95(9):1167-72. PubMed ID: 23425818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of bronchiolitis obliterans syndrome to other forms of chronic lung allograft dysfunction after lung transplantation.
    Woodrow JP; Shlobin OA; Barnett SD; Burton N; Nathan SD
    J Heart Lung Transplant; 2010 Oct; 29(10):1159-64. PubMed ID: 20580267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of a post-transplant chronic lung allograft dysfunction classification system.
    Van Herck A; Verleden SE; Sacreas A; Heigl T; Vanaudenaerde BM; Dupont LJ; Yserbyt J; Verbeken EK; Neyrinck AP; Van Raemdonck D; Verleden GM; Vos R
    J Heart Lung Transplant; 2019 Feb; 38(2):166-173. PubMed ID: 30391199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-dependent changes in the risk of death in pure bronchiolitis obliterans syndrome (BOS).
    Sato M; Ohmori-Matsuda K; Saito T; Matsuda Y; Hwang DM; Waddell TK; Singer LG; Keshavjee S
    J Heart Lung Transplant; 2013 May; 32(5):484-91. PubMed ID: 23433813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obliterative bronchiolitis following lung transplantation: from old to new concepts?
    Verleden GM; Vos R; De Vleeschauwer SI; Willems-Widyastuti A; Verleden SE; Dupont LJ; Van Raemdonck DE; Vanaudenaerde BM
    Transpl Int; 2009 Aug; 22(8):771-9. PubMed ID: 19490538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival determinants in lung transplant patients with chronic allograft dysfunction.
    Verleden GM; Vos R; Verleden SE; De Wever W; De Vleeschauwer SI; Willems-Widyastuti A; Scheers H; Dupont LJ; Van Raemdonck DE; Vanaudenaerde BM
    Transplantation; 2011 Sep; 92(6):703-8. PubMed ID: 21836537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of early pulmonary function changes after onset of chronic lung allograft dysfunction.
    Todd JL; Neely ML; Finlen Copeland CA; Frankel CW; Reynolds JM; Palmer SM
    J Heart Lung Transplant; 2019 Feb; 38(2):184-193. PubMed ID: 30466803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative chest CT for subtyping chronic lung allograft dysfunction and its association with survival.
    Horie M; Salazar P; Saito T; Binnie M; Brock K; Yasufuku K; Azad S; Keshavjee S; Martinu T; Paul N
    Clin Transplant; 2018 May; 32(5):e13233. PubMed ID: 29637624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of CT-SCAN score and volume measures to early identify restrictive allograft syndrome in single lung transplant recipients.
    Philippot Q; Debray MP; Bun R; Frija-Masson J; Bunel V; Morer L; Roux A; Picard C; Jebrak G; Dauriat G; Castier Y; Cazes A; Mal H; Taupin JL; Couffignal C; Brugière O
    J Heart Lung Transplant; 2020 Feb; 39(2):125-133. PubMed ID: 31836403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose computed tomography volumetry for subtyping chronic lung allograft dysfunction.
    Saito T; Horie M; Sato M; Nakajima D; Shoushtarizadeh H; Binnie M; Azad S; Hwang DM; Machuca TN; Waddell TK; Singer LG; Cypel M; Liu M; Paul NS; Keshavjee S
    J Heart Lung Transplant; 2016 Jan; 35(1):59-66. PubMed ID: 26342441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of biomechanical anatomical modeling via computed tomography for identification of restrictive allograft syndrome.
    Horie M; Saito T; Moseley J; D'Errico L; Salazar P; Nakajima D; Brock K; Yasufuku K; Binnie M; Keshavjee S; Paul N
    Clin Transplant; 2017 Aug; 31(8):. PubMed ID: 28658530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BALF cytokines in different phenotypes of chronic lung allograft dysfunction in lung transplant patients.
    Berastegui C; Gómez-Ollés S; Sánchez-Vidaurre S; Culebras M; Monforte V; López-Meseguer M; Bravo C; Ramon MA; Romero L; Sole J; Cruz MJ; Román A
    Clin Transplant; 2017 Mar; 31(3):. PubMed ID: 28008659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Revisiting the pathologic finding of diffuse alveolar damage after lung transplantation.
    Sato M; Hwang DM; Ohmori-Matsuda K; Chaparro C; Waddell TK; Singer LG; Hutcheon MA; Keshavjee S
    J Heart Lung Transplant; 2012 Apr; 31(4):354-63. PubMed ID: 22330935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of chronic lung allograft dysfunction patients with mixed phenotype: A single-center study.
    Verleden SE; Von Der Thüsen J; Van Herck A; Weynand B; Verbeken E; Verschakelen J; Dubbeldam A; Vanaudenaerde BM; Vos R; Verleden GM;
    Clin Transplant; 2020 Feb; 34(2):e13781. PubMed ID: 31958356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential cytokine, chemokine and growth factor expression in phenotypes of chronic lung allograft dysfunction.
    Verleden SE; Ruttens D; Vos R; Vandermeulen E; Moelants E; Mortier A; Van Raemdonck DE; Proost P; Schols D; Verleden GM; Vanaudenaerde BM
    Transplantation; 2015 Jan; 99(1):86-93. PubMed ID: 25050473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linking clinical phenotypes of chronic lung allograft dysfunction to changes in lung structure.
    Verleden SE; Vasilescu DM; McDonough JE; Ruttens D; Vos R; Vandermeulen E; Bellon H; Geenens R; Verbeken EK; Verschakelen J; Van Raemdonck DE; Wuyts WA; Sokolow Y; Knoop C; Cooper JD; Hogg JC; Verleden GM; Vanaudenaerde BM
    Eur Respir J; 2015 Nov; 46(5):1430-9. PubMed ID: 26113688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.